It is with great sorrow that we write about the demise of Leo Sachs, the Otto Meyerhof Professor of Molecular Biology, friend, colleague and brilliant scientist. Leo Focusing on blood stem cells, a small group of bone marrow cells that produce some 200 billion new blood cells every day, Leo initiated research that revolutionized understanding of stem cell biology, molecular and cellular hematology, and leukemia. In his initial experiments, Leo used normal feeder layer cells as a possible source of the factors that are required for growth and differentiation of the hematopoietic stem cells, and in 1961 described the culture of leukemic cells on these feeder layers (1, 2). Leo also conducted experiments with normal hematopoietic cells (3) (4) (5) and in 1963 discovered the first cell culture system for cloning and clonal differentiation of normal hematopoietic stem cells (3) . With this method, Leo then discovered the first protein regulators of this clonal growth and differentiation (5-7). He found that these regulators, later named colonystimulating factors (CSFs) and IL-3, induce viability, growth, and differentiation of specific cell lineages, such as macrophages and granulocytes (5-8), and are secreted by the cells that produce them (5-7); he also determined that there is a continued requirement for these proteins for cell viability, growth, and differentiation (9) (10) (11) (12) . Leo then showed that CSFs and IL-6 can induce granulocyte differentiation and that myeloid leukemic cells can be induced to differentiate to mature nondividing cells that are no more malignant (13) (14) (15) (16) (17) . These findings showed that cancer cells, which are genetically abnormal, can be epigenetically reprogrammed, and thereby created the basis for the clinical use of differentiation therapy (18) (19) (20) (21) . Indeed, one of these CSF proteins, G-CSF, is now used worldwide in a variety of clinical procedures, including boosting the production of infection-fighting white blood cells in cancer patients undergoing chemotherapy or radiation, and improving the success of bone marrow and peripheral blood cell transplants. Leo's findings on the control of hematopoiesis have pioneered new approaches and insights into stem cell biology that have led to new therapies.
At the Weizmann Institute, Leo initiated and fostered research in genetics and in 1960 established the Department of Genetics, which he headed for 27 years. The Institute's Department of Molecular Genetics, which was Leo's home until his last day, emerged from the historical Department of Genetics. In the laboratory, Leo was quite rigorous and preferred to follow his own intuition: this aspect could be described as "a lone wolf," but he chose well. Leo educated many gifted students who became well-recognized researchers, including Ernest Winocour, the late Yosi Aloni, Eliezer Huberman, Eitan (Sweden). All of these honors express the high esteem in which his scientific colleagues, as well as the medical community, held Leo.
In his capacity as a leading scientist, Leo also took an active role in the development and progress of the Weizmann Institute. Well known is his correspondence with Francis Crick, whom he approached more than 40 years ago to ask advice about the areas requiring development in the biological sciences. Because of his height, Leo was always a most impressive figure on campus, and despite his recent health problems he used to come to his office several times a week to satisfy his scientific curiosity. We shall always remember Leo for his contribution in shaping biology at the Weizmann Institute of Science, but mainly because of his crucial and durable contribution to the understanding of colonystimulating factors and to human health. Leo will be greatly missed by his four children, his wife Pnina, and their grandchildren, and by his many friends in Israel and around the world.
